Interferon Lambda-2 (IFNL2) Antibody Pair

Este producto es parte de IFNL2 - interferon lambda 2
Product Graph
1326€ (5 × 96 tests)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Interferon Lambda-2 (IFNL2) Antibody Pair
category
Antibody Pairs
provider
Abbexa
reference
abx370565
tested applications
ELISA

Description

Interferon Lambda-2 (IFNL2) Antibody Pair for use in Sandwich ELISA assay development.
This antibody pair contains:
Detection: 50 µg
Capture: 200 µg
Standard: 2 µg

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Antibody Pairs
Immunogen Target
Interferon Lambda-2 (IFNL2)
Reactivity
Human
Assay Data
Sandwich
Assay Type
Capture Antibody: 0.5 mg/ml  Biotin-Conjugated Detection Antibody: 0.2 mg/ml
Reconstitute the standard with Standard Diluent. The volume, and therefore standard concentration, should be determined by the end user.
Recommended Dilution
Dilute the Capture Antibody 125-fold with Coating Buffer.  Dilute the Biotin-Conjugated Detection Antibody 200-fold with Detection Antibody Diluent.  Optimal dilutions/concentrations should be determined by the end user.
Conjugation
Biotin
Size 1
5 × 96 tests
Size 2
10 × 96 tests
Form
Standard form: Lyophilized
Capture Ab: Liquid
Detection Ab: Liquid
Tested Applications
ELISA
Buffer
The Capture and Detection Antibody both contain 0.1% sodium azide.
Availability
Shipped within 5-20 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
Alias
IL28B,IL28C,IL-28B,IL-28C,IFN-lambda-3,IFN-lambda-4,Cytokine Zcyto22,Interleukin-28B,Interleukin-28C
Background
Antibody pair for IFNL2
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Descripción

Interferon Lambda 3 (IFNL3), also known as IL-28B, is a cytokine that belongs to the Type III interferon family, which plays a critical role in the innate immune system, particularly in antiviral defense. IFNL3, like other Type III interferons, activates signaling pathways that result in the expression of interferon-stimulated genes (ISGs), creating an antiviral state within cells. IFNL3 primarily targets epithelial cells, such as those lining the respiratory tract, gastrointestinal tract, and liver, which are common entry points for viral infections. The discovery of IFNL3 and its genetic variations has been of significant interest, especially due to its role in the treatment and clearance of hepatitis C virus (HCV) infections. Genetic polymorphisms in the IFNL3 gene are strong predictors of treatment response in HCV patients, influencing outcomes of both spontaneous viral clearance and antiviral therapy. This connection has made IFNL3 a focus of research in viral infections, where immune response to chronic infections is crucial.

Related Products

EH0194

Human IL-28A (Interleukin-28A) ELISA Kit

Ver Producto
FNab04262

IL-28A antibody

Ver Producto
Pr23018

Recombinant Human IL-28A

Ver Producto